Nurix Therapeutics is a clinical stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted protein degradation medicines, the next frontier in innovative drug design aimed at improving treatment options for patients with cancer
Who we are Acusensus is an Australian technology success story with offices across Australia, the United States, the United Kingdom, and New Zealand. Founded in 2018, we have developed world-leading technology focused on reducing road fatalities